0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted NGS Amplicon Sequencing Services Market Research Report 2026
Published Date: 2026-03-02
|
Report Code: QYRE-Auto-29Y19996
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted NGS Amplicon Sequencing Services Market Research Report 2026
BUY CHAPTERS

Global Targeted NGS Amplicon Sequencing Services Market Research Report 2026

Code: QYRE-Auto-29Y19996
Report
2026-03-02
Pages:165
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted NGS Amplicon Sequencing Services Market Size

The global Targeted NGS Amplicon Sequencing Services market was valued at US$ 785 million in 2025 and is anticipated to reach US$ 1464 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

Targeted NGS Amplicon Sequencing Services Market

Targeted NGS Amplicon Sequencing Services Market

Targeted NGS Amplicon Sequencing is a targeted next-generation sequencing approach that first amplifies specific genomic regions of interest using polymerase chain reaction (PCR) to generate target amplicons, then performs high-throughput sequencing on these enriched fragments to analyze genetic variations efficiently. It focuses on predefined genomic loci such as disease-related genes, mutation hotspots or biomarker regions, bypassing whole-genome sequencing, delivering focused data output with high sequencing depth and accuracy, and enabling rapid detection of single nucleotide polymorphisms, insertions, deletions and other genetic variants.
Demand for targeted NGS amplicon sequencing is driven by the expansion of precision medicine, clinical genetic testing, infectious disease pathogen identification and agricultural genomic breeding, with stable clinical demand in oncology companion diagnostics, hereditary disease screening and microbial detection, and emerging demand in agricultural trait selection and environmental sample monitoring. Business opportunities lie in developing high-specificity amplicon panel design for rare diseases and drug resistance monitoring, optimizing library preparation workflows to reduce turnaround time and cost, launching integrated detection platforms for clinical and field applications, and expanding application scenarios in personalized health management and food safety testing.
This report delivers a comprehensive overview of the global Targeted NGS Amplicon Sequencing Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted NGS Amplicon Sequencing Services. The Targeted NGS Amplicon Sequencing Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Targeted NGS Amplicon Sequencing Services market comprehensively. Regional market sizes by Target Region, by Application, by Sample Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted NGS Amplicon Sequencing Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Target Region, by Application, and by region.
Market Segmentation

Scope of Targeted NGS Amplicon Sequencing Services Market Report

Report Metric Details
Report Name Targeted NGS Amplicon Sequencing Services Market
Accounted market size in 2025 US$ 785 in million
Forecasted market size in 2032 US$ 1464 million
CAGR 9.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Target Region
  • Single-Gene Sequencing
  • Multi-Gene Panel Sequencing
  • Customized Region Sequencing
Segment by Sample Type
  • Blood Sample Sequencing
  • Tissue Sample Sequencing
  • Cell Sample Sequencing
Segment by Sequencing Depth
  • Low-Depth Sequencing
  • Medium-Depth Sequencing
  • High-Depth Sequencing
Segment by Application
  • Clinical Molecular Diagnostics
  • Human Genetics & Population Research
  • Agricultural Biotechnology & Breeding
  • Industrial Biotechnology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IDT, Azenta Life Sciences, Eurofins Genomics, Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic, CD Genomics, AllGenetics, Charles River, Source BioScience, AGRF, Plasmidsaurus, Eurofins Scientific, Charles River Laboratories, ABM, Zymo Research, Paragon Genomics, Quintara Bio, HyLabs, MUGTC, SeqCoast Genomics, Shanghai Baiqu Biomedical Technology, Illumina, Guangzhou IGE Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Target Region, by Application, by Sample Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Targeted NGS Amplicon Sequencing Services companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Target Region, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Targeted NGS Amplicon Sequencing Services Market growing?

Ans: The Targeted NGS Amplicon Sequencing Services Market witnessing a CAGR of 9.2% during the forecast period 2026-2032.

What is the Targeted NGS Amplicon Sequencing Services Market size in 2032?

Ans: The Targeted NGS Amplicon Sequencing Services Market size in 2032 will be US$ 1464 million.

Who are the main players in the Targeted NGS Amplicon Sequencing Services Market report?

Ans: The main players in the Targeted NGS Amplicon Sequencing Services Market are IDT, Azenta Life Sciences, Eurofins Genomics, Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic, CD Genomics, AllGenetics, Charles River, Source BioScience, AGRF, Plasmidsaurus, Eurofins Scientific, Charles River Laboratories, ABM, Zymo Research, Paragon Genomics, Quintara Bio, HyLabs, MUGTC, SeqCoast Genomics, Shanghai Baiqu Biomedical Technology, Illumina, Guangzhou IGE Biotechnology

What are the Application segmentation covered in the Targeted NGS Amplicon Sequencing Services Market report?

Ans: The Applications covered in the Targeted NGS Amplicon Sequencing Services Market report are Clinical Molecular Diagnostics, Human Genetics & Population Research, Agricultural Biotechnology & Breeding, Industrial Biotechnology, Others

What are the Type segmentation covered in the Targeted NGS Amplicon Sequencing Services Market report?

Ans: The Types covered in the Targeted NGS Amplicon Sequencing Services Market report are Blood Sample Sequencing, Tissue Sample Sequencing, Cell Sample Sequencing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Target Region
1.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Target Region: 2021 vs 2025 vs 2032
1.2.2 Single-Gene Sequencing
1.2.3 Multi-Gene Panel Sequencing
1.2.4 Customized Region Sequencing
1.3 Market by Sample Type
1.3.1 Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Sample Type: 2021 vs 2025 vs 2032
1.3.2 Blood Sample Sequencing
1.3.3 Tissue Sample Sequencing
1.3.4 Cell Sample Sequencing
1.4 Market by Sequencing Depth
1.4.1 Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Sequencing Depth: 2021 vs 2025 vs 2032
1.4.2 Low-Depth Sequencing
1.4.3 Medium-Depth Sequencing
1.4.4 High-Depth Sequencing
1.5 Market by Application
1.5.1 Global Targeted NGS Amplicon Sequencing Services Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Clinical Molecular Diagnostics
1.5.3 Human Genetics & Population Research
1.5.4 Agricultural Biotechnology & Breeding
1.5.5 Industrial Biotechnology
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Targeted NGS Amplicon Sequencing Services Market Perspective (2021–2032)
2.2 Global Targeted NGS Amplicon Sequencing Services Growth Trends by Region
2.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Targeted NGS Amplicon Sequencing Services Historic Market Size by Region (2021–2026)
2.2.3 Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Region (2027–2032)
2.3 Targeted NGS Amplicon Sequencing Services Market Dynamics
2.3.1 Targeted NGS Amplicon Sequencing Services Industry Trends
2.3.2 Targeted NGS Amplicon Sequencing Services Market Drivers
2.3.3 Targeted NGS Amplicon Sequencing Services Market Challenges
2.3.4 Targeted NGS Amplicon Sequencing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted NGS Amplicon Sequencing Services Players by Revenue
3.1.1 Global Top Targeted NGS Amplicon Sequencing Services Players by Revenue (2021–2026)
3.1.2 Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Targeted NGS Amplicon Sequencing Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Targeted NGS Amplicon Sequencing Services Revenue
3.4 Global Targeted NGS Amplicon Sequencing Services Market Concentration Ratio
3.4.1 Global Targeted NGS Amplicon Sequencing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted NGS Amplicon Sequencing Services Revenue in 2025
3.5 Global Key Players of Targeted NGS Amplicon Sequencing Services Head Offices and Areas Served
3.6 Global Key Players of Targeted NGS Amplicon Sequencing Services, Products and Applications
3.7 Global Key Players of Targeted NGS Amplicon Sequencing Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Targeted NGS Amplicon Sequencing Services Breakdown Data by Target Region
4.1 Global Targeted NGS Amplicon Sequencing Services Historic Market Size by Target Region (2021–2026)
4.2 Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Target Region (2027–2032)
5 Targeted NGS Amplicon Sequencing Services Breakdown Data by Application
5.1 Global Targeted NGS Amplicon Sequencing Services Historic Market Size by Application (2021–2026)
5.2 Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Targeted NGS Amplicon Sequencing Services Market Size (2021–2032)
6.2 North America Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Targeted NGS Amplicon Sequencing Services Market Size by Country (2021–2026)
6.4 North America Targeted NGS Amplicon Sequencing Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted NGS Amplicon Sequencing Services Market Size (2021–2032)
7.2 Europe Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (2021–2026)
7.4 Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size (2021–2032)
8.2 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Targeted NGS Amplicon Sequencing Services Market Size (2021–2032)
9.2 Latin America Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Targeted NGS Amplicon Sequencing Services Market Size by Country (2021–2026)
9.4 Latin America Targeted NGS Amplicon Sequencing Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size (2021–2032)
10.2 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IDT
11.1.1 IDT Company Details
11.1.2 IDT Business Overview
11.1.3 IDT Targeted NGS Amplicon Sequencing Services Introduction
11.1.4 IDT Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.1.5 IDT Recent Development
11.2 Azenta Life Sciences
11.2.1 Azenta Life Sciences Company Details
11.2.2 Azenta Life Sciences Business Overview
11.2.3 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Introduction
11.2.4 Azenta Life Sciences Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.2.5 Azenta Life Sciences Recent Development
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Company Details
11.3.2 Eurofins Genomics Business Overview
11.3.3 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Introduction
11.3.4 Eurofins Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.3.5 Eurofins Genomics Recent Development
11.4 Novogene
11.4.1 Novogene Company Details
11.4.2 Novogene Business Overview
11.4.3 Novogene Targeted NGS Amplicon Sequencing Services Introduction
11.4.4 Novogene Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.4.5 Novogene Recent Development
11.5 BGI (BGI Genomics)
11.5.1 BGI (BGI Genomics) Company Details
11.5.2 BGI (BGI Genomics) Business Overview
11.5.3 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Introduction
11.5.4 BGI (BGI Genomics) Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.5.5 BGI (BGI Genomics) Recent Development
11.6 Macrogen
11.6.1 Macrogen Company Details
11.6.2 Macrogen Business Overview
11.6.3 Macrogen Targeted NGS Amplicon Sequencing Services Introduction
11.6.4 Macrogen Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.6.5 Macrogen Recent Development
11.7 Psomagen
11.7.1 Psomagen Company Details
11.7.2 Psomagen Business Overview
11.7.3 Psomagen Targeted NGS Amplicon Sequencing Services Introduction
11.7.4 Psomagen Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.7.5 Psomagen Recent Development
11.8 SeqMatic
11.8.1 SeqMatic Company Details
11.8.2 SeqMatic Business Overview
11.8.3 SeqMatic Targeted NGS Amplicon Sequencing Services Introduction
11.8.4 SeqMatic Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.8.5 SeqMatic Recent Development
11.9 CD Genomics
11.9.1 CD Genomics Company Details
11.9.2 CD Genomics Business Overview
11.9.3 CD Genomics Targeted NGS Amplicon Sequencing Services Introduction
11.9.4 CD Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.9.5 CD Genomics Recent Development
11.10 AllGenetics
11.10.1 AllGenetics Company Details
11.10.2 AllGenetics Business Overview
11.10.3 AllGenetics Targeted NGS Amplicon Sequencing Services Introduction
11.10.4 AllGenetics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.10.5 AllGenetics Recent Development
11.11 Charles River
11.11.1 Charles River Company Details
11.11.2 Charles River Business Overview
11.11.3 Charles River Targeted NGS Amplicon Sequencing Services Introduction
11.11.4 Charles River Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.11.5 Charles River Recent Development
11.12 Source BioScience
11.12.1 Source BioScience Company Details
11.12.2 Source BioScience Business Overview
11.12.3 Source BioScience Targeted NGS Amplicon Sequencing Services Introduction
11.12.4 Source BioScience Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.12.5 Source BioScience Recent Development
11.13 AGRF
11.13.1 AGRF Company Details
11.13.2 AGRF Business Overview
11.13.3 AGRF Targeted NGS Amplicon Sequencing Services Introduction
11.13.4 AGRF Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.13.5 AGRF Recent Development
11.14 Plasmidsaurus
11.14.1 Plasmidsaurus Company Details
11.14.2 Plasmidsaurus Business Overview
11.14.3 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Introduction
11.14.4 Plasmidsaurus Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.14.5 Plasmidsaurus Recent Development
11.15 Eurofins Scientific
11.15.1 Eurofins Scientific Company Details
11.15.2 Eurofins Scientific Business Overview
11.15.3 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Introduction
11.15.4 Eurofins Scientific Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.15.5 Eurofins Scientific Recent Development
11.16 Charles River Laboratories
11.16.1 Charles River Laboratories Company Details
11.16.2 Charles River Laboratories Business Overview
11.16.3 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Introduction
11.16.4 Charles River Laboratories Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.16.5 Charles River Laboratories Recent Development
11.17 ABM
11.17.1 ABM Company Details
11.17.2 ABM Business Overview
11.17.3 ABM Targeted NGS Amplicon Sequencing Services Introduction
11.17.4 ABM Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.17.5 ABM Recent Development
11.18 Zymo Research
11.18.1 Zymo Research Company Details
11.18.2 Zymo Research Business Overview
11.18.3 Zymo Research Targeted NGS Amplicon Sequencing Services Introduction
11.18.4 Zymo Research Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.18.5 Zymo Research Recent Development
11.19 Paragon Genomics
11.19.1 Paragon Genomics Company Details
11.19.2 Paragon Genomics Business Overview
11.19.3 Paragon Genomics Targeted NGS Amplicon Sequencing Services Introduction
11.19.4 Paragon Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.19.5 Paragon Genomics Recent Development
11.20 Quintara Bio
11.20.1 Quintara Bio Company Details
11.20.2 Quintara Bio Business Overview
11.20.3 Quintara Bio Targeted NGS Amplicon Sequencing Services Introduction
11.20.4 Quintara Bio Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.20.5 Quintara Bio Recent Development
11.21 HyLabs
11.21.1 HyLabs Company Details
11.21.2 HyLabs Business Overview
11.21.3 HyLabs Targeted NGS Amplicon Sequencing Services Introduction
11.21.4 HyLabs Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.21.5 HyLabs Recent Development
11.22 MUGTC
11.22.1 MUGTC Company Details
11.22.2 MUGTC Business Overview
11.22.3 MUGTC Targeted NGS Amplicon Sequencing Services Introduction
11.22.4 MUGTC Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.22.5 MUGTC Recent Development
11.23 SeqCoast Genomics
11.23.1 SeqCoast Genomics Company Details
11.23.2 SeqCoast Genomics Business Overview
11.23.3 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Introduction
11.23.4 SeqCoast Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.23.5 SeqCoast Genomics Recent Development
11.24 Shanghai Baiqu Biomedical Technology
11.24.1 Shanghai Baiqu Biomedical Technology Company Details
11.24.2 Shanghai Baiqu Biomedical Technology Business Overview
11.24.3 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Introduction
11.24.4 Shanghai Baiqu Biomedical Technology Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.24.5 Shanghai Baiqu Biomedical Technology Recent Development
11.25 Illumina
11.25.1 Illumina Company Details
11.25.2 Illumina Business Overview
11.25.3 Illumina Targeted NGS Amplicon Sequencing Services Introduction
11.25.4 Illumina Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.25.5 Illumina Recent Development
11.26 Guangzhou IGE Biotechnology
11.26.1 Guangzhou IGE Biotechnology Company Details
11.26.2 Guangzhou IGE Biotechnology Business Overview
11.26.3 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Introduction
11.26.4 Guangzhou IGE Biotechnology Revenue in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
11.26.5 Guangzhou IGE Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Target Region (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Single-Gene Sequencing
 Table 3. Key Players of Multi-Gene Panel Sequencing
 Table 4. Key Players of Customized Region Sequencing
 Table 5. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Sample Type (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Key Players of Blood Sample Sequencing
 Table 7. Key Players of Tissue Sample Sequencing
 Table 8. Key Players of Cell Sample Sequencing
 Table 9. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Sequencing Depth (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Key Players of Low-Depth Sequencing
 Table 11. Key Players of Medium-Depth Sequencing
 Table 12. Key Players of High-Depth Sequencing
 Table 13. Global Targeted NGS Amplicon Sequencing Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 14. Global Targeted NGS Amplicon Sequencing Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 15. Global Targeted NGS Amplicon Sequencing Services Market Size by Region (US$ Million), 2021–2026
 Table 16. Global Targeted NGS Amplicon Sequencing Services Market Share by Region (2021–2026)
 Table 17. Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 18. Global Targeted NGS Amplicon Sequencing Services Market Share by Region (2027–2032)
 Table 19. Targeted NGS Amplicon Sequencing Services Market Trends
 Table 20. Targeted NGS Amplicon Sequencing Services Market Drivers
 Table 21. Targeted NGS Amplicon Sequencing Services Market Challenges
 Table 22. Targeted NGS Amplicon Sequencing Services Market Restraints
 Table 23. Global Targeted NGS Amplicon Sequencing Services Revenue by Players (US$ Million), 2021–2026
 Table 24. Global Targeted NGS Amplicon Sequencing Services Market Share by Players (2021–2026)
 Table 25. Global Top Targeted NGS Amplicon Sequencing Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted NGS Amplicon Sequencing Services Revenue, 2025
 Table 26. Ranking of Global Top Targeted NGS Amplicon Sequencing Services Companies by Revenue (US$ Million) in 2025
 Table 27. Global 5 Largest Players Market Share by Targeted NGS Amplicon Sequencing Services Revenue (CR5 and HHI), 2021–2026
 Table 28. Global Key Players of Targeted NGS Amplicon Sequencing Services, Headquarters and Area Served
 Table 29. Global Key Players of Targeted NGS Amplicon Sequencing Services, Products and Applications
 Table 30. Global Key Players of Targeted NGS Amplicon Sequencing Services, Date of General Availability (GA)
 Table 31. Mergers and Acquisitions, Expansion Plans
 Table 32. Global Targeted NGS Amplicon Sequencing Services Market Size by Target Region (US$ Million), 2021–2026
 Table 33. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Target Region (2021–2026)
 Table 34. Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Target Region (US$ Million), 2027–2032
 Table 35. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Target Region (2027–2032)
 Table 36. Global Targeted NGS Amplicon Sequencing Services Market Size by Application (US$ Million), 2021–2026
 Table 37. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2021–2026)
 Table 38. Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 39. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2027–2032)
 Table 40. North America Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. North America Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2021–2026
 Table 42. North America Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2027–2032
 Table 43. Europe Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2021–2026
 Table 45. Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2027–2032
 Table 46. Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Region (US$ Million), 2021–2026
 Table 48. Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Region (US$ Million), 2027–2032
 Table 49. Latin America Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 50. Latin America Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2021–2026
 Table 51. Latin America Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2027–2032
 Table 52. Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2021–2026
 Table 54. Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (US$ Million), 2027–2032
 Table 55. IDT Company Details
 Table 56. IDT Business Overview
 Table 57. IDT Targeted NGS Amplicon Sequencing Services Product
 Table 58. IDT Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 59. IDT Recent Development
 Table 60. Azenta Life Sciences Company Details
 Table 61. Azenta Life Sciences Business Overview
 Table 62. Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product
 Table 63. Azenta Life Sciences Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 64. Azenta Life Sciences Recent Development
 Table 65. Eurofins Genomics Company Details
 Table 66. Eurofins Genomics Business Overview
 Table 67. Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product
 Table 68. Eurofins Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 69. Eurofins Genomics Recent Development
 Table 70. Novogene Company Details
 Table 71. Novogene Business Overview
 Table 72. Novogene Targeted NGS Amplicon Sequencing Services Product
 Table 73. Novogene Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 74. Novogene Recent Development
 Table 75. BGI (BGI Genomics) Company Details
 Table 76. BGI (BGI Genomics) Business Overview
 Table 77. BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product
 Table 78. BGI (BGI Genomics) Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 79. BGI (BGI Genomics) Recent Development
 Table 80. Macrogen Company Details
 Table 81. Macrogen Business Overview
 Table 82. Macrogen Targeted NGS Amplicon Sequencing Services Product
 Table 83. Macrogen Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 84. Macrogen Recent Development
 Table 85. Psomagen Company Details
 Table 86. Psomagen Business Overview
 Table 87. Psomagen Targeted NGS Amplicon Sequencing Services Product
 Table 88. Psomagen Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 89. Psomagen Recent Development
 Table 90. SeqMatic Company Details
 Table 91. SeqMatic Business Overview
 Table 92. SeqMatic Targeted NGS Amplicon Sequencing Services Product
 Table 93. SeqMatic Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 94. SeqMatic Recent Development
 Table 95. CD Genomics Company Details
 Table 96. CD Genomics Business Overview
 Table 97. CD Genomics Targeted NGS Amplicon Sequencing Services Product
 Table 98. CD Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 99. CD Genomics Recent Development
 Table 100. AllGenetics Company Details
 Table 101. AllGenetics Business Overview
 Table 102. AllGenetics Targeted NGS Amplicon Sequencing Services Product
 Table 103. AllGenetics Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 104. AllGenetics Recent Development
 Table 105. Charles River Company Details
 Table 106. Charles River Business Overview
 Table 107. Charles River Targeted NGS Amplicon Sequencing Services Product
 Table 108. Charles River Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 109. Charles River Recent Development
 Table 110. Source BioScience Company Details
 Table 111. Source BioScience Business Overview
 Table 112. Source BioScience Targeted NGS Amplicon Sequencing Services Product
 Table 113. Source BioScience Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 114. Source BioScience Recent Development
 Table 115. AGRF Company Details
 Table 116. AGRF Business Overview
 Table 117. AGRF Targeted NGS Amplicon Sequencing Services Product
 Table 118. AGRF Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 119. AGRF Recent Development
 Table 120. Plasmidsaurus Company Details
 Table 121. Plasmidsaurus Business Overview
 Table 122. Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product
 Table 123. Plasmidsaurus Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 124. Plasmidsaurus Recent Development
 Table 125. Eurofins Scientific Company Details
 Table 126. Eurofins Scientific Business Overview
 Table 127. Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product
 Table 128. Eurofins Scientific Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 129. Eurofins Scientific Recent Development
 Table 130. Charles River Laboratories Company Details
 Table 131. Charles River Laboratories Business Overview
 Table 132. Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product
 Table 133. Charles River Laboratories Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 134. Charles River Laboratories Recent Development
 Table 135. ABM Company Details
 Table 136. ABM Business Overview
 Table 137. ABM Targeted NGS Amplicon Sequencing Services Product
 Table 138. ABM Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 139. ABM Recent Development
 Table 140. Zymo Research Company Details
 Table 141. Zymo Research Business Overview
 Table 142. Zymo Research Targeted NGS Amplicon Sequencing Services Product
 Table 143. Zymo Research Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 144. Zymo Research Recent Development
 Table 145. Paragon Genomics Company Details
 Table 146. Paragon Genomics Business Overview
 Table 147. Paragon Genomics Targeted NGS Amplicon Sequencing Services Product
 Table 148. Paragon Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 149. Paragon Genomics Recent Development
 Table 150. Quintara Bio Company Details
 Table 151. Quintara Bio Business Overview
 Table 152. Quintara Bio Targeted NGS Amplicon Sequencing Services Product
 Table 153. Quintara Bio Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 154. Quintara Bio Recent Development
 Table 155. HyLabs Company Details
 Table 156. HyLabs Business Overview
 Table 157. HyLabs Targeted NGS Amplicon Sequencing Services Product
 Table 158. HyLabs Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 159. HyLabs Recent Development
 Table 160. MUGTC Company Details
 Table 161. MUGTC Business Overview
 Table 162. MUGTC Targeted NGS Amplicon Sequencing Services Product
 Table 163. MUGTC Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 164. MUGTC Recent Development
 Table 165. SeqCoast Genomics Company Details
 Table 166. SeqCoast Genomics Business Overview
 Table 167. SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product
 Table 168. SeqCoast Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 169. SeqCoast Genomics Recent Development
 Table 170. Shanghai Baiqu Biomedical Technology Company Details
 Table 171. Shanghai Baiqu Biomedical Technology Business Overview
 Table 172. Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product
 Table 173. Shanghai Baiqu Biomedical Technology Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 174. Shanghai Baiqu Biomedical Technology Recent Development
 Table 175. Illumina Company Details
 Table 176. Illumina Business Overview
 Table 177. Illumina Targeted NGS Amplicon Sequencing Services Product
 Table 178. Illumina Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 179. Illumina Recent Development
 Table 180. Guangzhou IGE Biotechnology Company Details
 Table 181. Guangzhou IGE Biotechnology Business Overview
 Table 182. Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product
 Table 183. Guangzhou IGE Biotechnology Revenue in Targeted NGS Amplicon Sequencing Services Business (US$ Million), 2021–2026
 Table 184. Guangzhou IGE Biotechnology Recent Development
 Table 185. Research Programs/Design for This Report
 Table 186. Key Data Information from Secondary Sources
 Table 187. Key Data Information from Primary Sources
 Table 188. Authors List of This Report


List of Figures
 Figure 1. Targeted NGS Amplicon Sequencing Services Picture
 Figure 2. Global Targeted NGS Amplicon Sequencing Services Market Size Comparison by Target Region (US$ Million), 2021–2032
 Figure 3. Global Targeted NGS Amplicon Sequencing Services Market Share by Target Region: 2025 vs 2032
 Figure 4. Single-Gene Sequencing Features
 Figure 5. Multi-Gene Panel Sequencing Features
 Figure 6. Customized Region Sequencing Features
 Figure 7. Global Targeted NGS Amplicon Sequencing Services Market Size Comparison by Sample Type (US$ Million), 2021–2032
 Figure 8. Blood Sample Sequencing Features
 Figure 9. Tissue Sample Sequencing Features
 Figure 10. Cell Sample Sequencing Features
 Figure 11. Global Targeted NGS Amplicon Sequencing Services Market Size Comparison by Sequencing Depth (US$ Million), 2021–2032
 Figure 12. Low-Depth Sequencing Features
 Figure 13. Medium-Depth Sequencing Features
 Figure 14. High-Depth Sequencing Features
 Figure 15. Global Targeted NGS Amplicon Sequencing Services Market Size by Application (US$ Million), 2021–2032
 Figure 16. Global Targeted NGS Amplicon Sequencing Services Market Share by Application: 2025 vs 2032
 Figure 17. Clinical Molecular Diagnostics Case Studies
 Figure 18. Human Genetics & Population Research Case Studies
 Figure 19. Agricultural Biotechnology & Breeding Case Studies
 Figure 20. Industrial Biotechnology Case Studies
 Figure 21. Others Case Studies
 Figure 22. Targeted NGS Amplicon Sequencing Services Report Years Considered
 Figure 23. Global Targeted NGS Amplicon Sequencing Services Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 24. Global Targeted NGS Amplicon Sequencing Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 25. Global Targeted NGS Amplicon Sequencing Services Market Share by Region: 2025 vs 2032
 Figure 26. Global Targeted NGS Amplicon Sequencing Services Market Share by Players in 2025
 Figure 27. Global Targeted NGS Amplicon Sequencing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 28. The Top 10 and 5 Players Market Share by Targeted NGS Amplicon Sequencing Services Revenue in 2025
 Figure 29. North America Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. North America Targeted NGS Amplicon Sequencing Services Market Share by Country (2021–2032)
 Figure 31. United States Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Canada Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Europe Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Europe Targeted NGS Amplicon Sequencing Services Market Share by Country (2021–2032)
 Figure 35. Germany Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. France Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. U.K. Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Italy Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Russia Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Ireland Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Share by Region (2021–2032)
 Figure 43. China Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Japan Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. South Korea Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Southeast Asia Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. India Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Australia & New Zealand Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Latin America Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Latin America Targeted NGS Amplicon Sequencing Services Market Share by Country (2021–2032)
 Figure 51. Mexico Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Brazil Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Share by Country (2021–2032)
 Figure 55. Israel Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 57. UAE Targeted NGS Amplicon Sequencing Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 58. IDT Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 59. Azenta Life Sciences Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 60. Eurofins Genomics Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 61. Novogene Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 62. BGI (BGI Genomics) Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 63. Macrogen Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 64. Psomagen Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 65. SeqMatic Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 66. CD Genomics Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 67. AllGenetics Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 68. Charles River Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 69. Source BioScience Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 70. AGRF Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 71. Plasmidsaurus Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 72. Eurofins Scientific Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 73. Charles River Laboratories Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 74. ABM Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 75. Zymo Research Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 76. Paragon Genomics Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 77. Quintara Bio Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 78. HyLabs Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 79. MUGTC Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 80. SeqCoast Genomics Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 81. Shanghai Baiqu Biomedical Technology Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 82. Illumina Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 83. Guangzhou IGE Biotechnology Revenue Growth Rate in Targeted NGS Amplicon Sequencing Services Business (2021–2026)
 Figure 84. Bottom-up and Top-down Approaches for This Report
 Figure 85. Data Triangulation
 Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS